Financial institutions, including UBS and Deutsche Bank, upgraded Elevance Health to Buy rating on May 28, 2026, while it operates as a health insurer in the United States.
1 report, 1 independent
Updated May 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Financial institutions, including UBS and Deutsche Bank, upgraded Elevance Health to Buy rating on May 28, 2026, while it operates as a health insurer in the United States.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Elevance Health, Inc.
American healthcare company
Nothing else this week.
-
UBS
Swiss multinational investment bank and financial services company
-
Deutsche Bank
German global banking and financial services company
Related events
- Elevance Health and Privia Health Group are both facing market scrutiny.
- Morgan Stanley and Raymond James Financial raised their price objectives for Elevance Health, Inc. on September 15, 2026.
- Tenet Healthcare and Elevance Health, Inc. are noted as companies competing in the large-cap U.S. healthcare market and operating as health benefits providers.